News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
622,153 Results
Type
Article (47898)
Company Profile (203)
Press Release (574041)
Multimedia
Podcasts (150)
Webinars (22)
Section
Business (172890)
Career Advice (2543)
Deals (31925)
Drug Delivery (134)
Drug Development (76477)
Employer Resources (164)
FDA (16421)
Job Trends (13346)
News (306192)
Policy (32052)
Tag
Academia (2379)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (117)
Alliances (43479)
ALS (138)
Alzheimer's disease (1630)
Antibody-drug conjugate (ADC) (244)
Approvals (16445)
Artificial intelligence (420)
Autoimmune disease (90)
Automation (22)
Bankruptcy (325)
Best Places to Work (9918)
BIOSECURE Act (23)
Biosimilars (165)
Biotechnology (100)
Bladder cancer (133)
Brain cancer (47)
Breast cancer (477)
Cancer (3755)
Cardiovascular disease (327)
Career advice (2147)
Career pathing (38)
CAR-T (217)
CDC (57)
Cell therapy (614)
Cervical cancer (30)
Clinical research (64256)
Collaboration (1248)
Company closure (4)
Compensation (934)
Complete response letters (60)
COVID-19 (2740)
CRISPR (72)
C-suite (553)
Cystic fibrosis (127)
Data (4442)
Decentralized trials (2)
Denatured (40)
Depression (108)
Diabetes (416)
Diagnostics (5713)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (184)
Drug pricing (191)
Drug shortages (35)
Duchenne muscular dystrophy (199)
Earnings (71371)
Editorial (55)
Employer branding (20)
Employer resources (147)
Events (94960)
Executive appointments (899)
FDA (18880)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (12)
Funding (1095)
Gene editing (155)
Generative AI (35)
Gene therapy (504)
GLP-1 (985)
Government (4219)
Grass and pollen (8)
Guidances (363)
Healthcare (15537)
HIV (45)
Huntington's disease (39)
IgA nephropathy (62)
Immunology and inflammation (245)
Immuno-oncology (22)
Indications (55)
Infectious disease (2965)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (89)
Intellectual property (185)
Interviews (468)
IPO (15194)
IRA (57)
Job creations (3770)
Job search strategy (1773)
Kidney cancer (16)
Labor market (72)
Layoffs (607)
Leadership (37)
Legal (7751)
Liver cancer (85)
Longevity (12)
Lung cancer (548)
Lymphoma (256)
Machine learning (29)
Management (55)
Manufacturing (604)
MASH (139)
Medical device (11687)
Medtech (11708)
Mergers & acquisitions (17604)
Metabolic disorders (1111)
Multiple sclerosis (126)
NASH (23)
Neurodegenerative disease (213)
Neuropsychiatric disorders (60)
Neuroscience (2609)
NextGen: Class of 2025 (5283)
Non-profit (3338)
Now hiring (35)
Obesity (553)
Opinion (283)
Ovarian cancer (124)
Pain (160)
Pancreatic cancer (162)
Parkinson's disease (235)
Partnered (24)
Patents (405)
Patient recruitment (304)
Peanut (51)
People (52070)
Pharmaceutical (82)
Pharmacy benefit managers (28)
Phase I (19299)
Phase II (27949)
Phase III (22196)
Pipeline (2694)
Policy (296)
Postmarket research (2553)
Preclinical (8022)
Press Release (48)
Prostate cancer (197)
Psychedelics (50)
Radiopharmaceuticals (244)
Rare diseases (660)
Real estate (5238)
Recruiting (68)
Regulatory (23644)
Reports (40)
Research institute (2218)
Resumes & cover letters (418)
Rett syndrome (15)
RNA editing (13)
RSV (67)
Schizophrenia (135)
Series A (190)
Series B (139)
Service/supplier (10)
Sickle cell disease (78)
Special edition (24)
Spinal muscular atrophy (154)
Sponsored (40)
Startups (3269)
State (2)
Stomach cancer (17)
Supply chain (98)
Tariffs (96)
The Weekly (108)
Vaccines (1009)
Venture capital (66)
Weight loss (397)
Women's health (48)
Worklife (21)
Date
Today (188)
Last 7 days (734)
Last 30 days (2659)
Last 365 days (29915)
2025 (24840)
2024 (33288)
2023 (37222)
2022 (47705)
2021 (51385)
2020 (48650)
2019 (39201)
2018 (29904)
2017 (30547)
2016 (29175)
2015 (32677)
2014 (26562)
2013 (22192)
2012 (23752)
2011 (24429)
2010 (22346)
Location
Africa (771)
Alabama (61)
Alaska (7)
Arizona (216)
Arkansas (11)
Asia (38208)
Australia (6240)
California (8885)
Canada (2448)
China (835)
Colorado (372)
Connecticut (410)
Delaware (261)
Europe (87555)
Florida (1352)
Georgia (274)
Hawaii (3)
Idaho (41)
Illinois (648)
India (50)
Indiana (395)
Iowa (18)
Japan (319)
Kansas (105)
Kentucky (32)
Louisiana (14)
Maine (69)
Maryland (1181)
Massachusetts (6566)
Michigan (238)
Minnesota (479)
Mississippi (3)
Missouri (99)
Montana (17)
Nebraska (22)
Nevada (97)
New Hampshire (62)
New Jersey (2503)
New Mexico (16)
New York (2359)
North Carolina (1239)
North Dakota (7)
Northern California (4171)
Ohio (242)
Oklahoma (16)
Oregon (33)
Pennsylvania (1799)
Puerto Rico (13)
Rhode Island (30)
South America (1139)
South Carolina (47)
South Dakota (1)
Southern California (3437)
Tennessee (136)
Texas (1323)
United States (31938)
Utah (229)
Virginia (221)
Washington D.C. (74)
Washington State (720)
West Virginia (4)
Wisconsin (83)
Wyoming (1)
622,153 Results for "veloxis pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veloxis Pharmaceuticals to Present at 2025 World Transplant Congress
July 31, 2025
·
4 min read
Bio NC
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
May 30, 2024
·
5 min read
Press Releases
Veloxis Pharmaceuticals Receives Approval from USAN for “Pegrizeprument” as Nonproprietary Name for VEL-101
February 26, 2025
·
3 min read
FDA
FDA’s Lost Leaders: Where Are They Now?
After a chaotic year that has seen the attrition of over half the FDA’s senior leadership, many of these individuals have landed new roles—at Eli Lilly, Pfizer, Iovance and more. The FDA’s loss, it seems, is largely the pharmaceutical industry’s gain.
October 20, 2025
·
8 min read
·
Heather McKenzie
Deals
4DMT Sends Eye Disease Asset’s Asia Rights to Otsuka for $85M Upfront
Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a VEGF-C inhibitory RNAi with Regeneron’s Eylea into a single ocular injection.
October 31, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis
October 20, 2025
·
5 min read
Press Releases
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
October 15, 2025
·
4 min read
Press Releases
Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
October 22, 2025
·
5 min read
Huntington’s disease
UniQure’s Huntington’s Breakthrough Brings Hope to Patients but Experts Urge Caution
Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only disappointment in recent years—but one expert worries that communication of the results is creating “false expectations.”
October 27, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration
October 2, 2025
·
4 min read
1 of 62,216
Next
